Works by Kawamura, Takahisa


Results: 39
    1
    2

    Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251344010
    By:
    • Ishihara, Masashi;
    • Kawamura, Takahisa;
    • Namba, Yukiko;
    • Takeyasu, Yuki;
    • Hasegawa, Yukihiro;
    • Sato, Yuki;
    • Negi, Yoshiki;
    • Oba, Tomohiro;
    • Sumi, Toshiyuki;
    • Hirata, Hirokuni;
    • Funabashi, Hidemitsu;
    • Oya, Yuko;
    • Kikuchi, Hajime;
    • Katsurada, Naoko;
    • Nakatani, Takeshi;
    • Tanimura, Keiko;
    • Nakagawa, Taku;
    • Takeda, Naoya;
    • Asami, Takahiro;
    • Honjo, Osamu
    Publication type:
    Article
    3
    4
    5

    Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).

    Published in:
    Targeted Oncology, 2024, v. 19, n. 3, p. 423, doi. 10.1007/s11523-024-01048-x
    By:
    • Nishioka, Naoya;
    • Imai, Hisao;
    • Endo, Masahiro;
    • Notsu, Akifumi;
    • Doshita, Kosei;
    • Igawa, Satoshi;
    • Yokouchi, Hiroshi;
    • Ninomiya, Takashi;
    • Tokito, Takaaki;
    • Soda, Sayo;
    • Fujiwara, Takasato;
    • Asao, Tetsuhiko;
    • Nakamichi, Shinji;
    • Kawamura, Takahisa;
    • Inomata, Minehiko;
    • Nakashima, Kazuhisa;
    • Ito, Kentaro;
    • Goto, Yasuhiro;
    • Umeda, Yukihiro;
    • Hirai, Soichi
    Publication type:
    Article
    6

    Trophoblast cell-surface antigen 2 expression in lung cancer patients and the effects of anti-cancer treatments.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2455, doi. 10.1007/s00432-021-03784-3
    By:
    • Omori, Shota;
    • Muramatsu, Koji;
    • Kawata, Takuya;
    • Miyawaki, Eriko;
    • Miyawaki, Taichi;
    • Mamesaya, Nobuaki;
    • Kawamura, Takahisa;
    • Kobayashi, Haruki;
    • Nakashima, Kazuhisa;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Sugino, Takashi;
    • Takahashi, Toshiaki
    Publication type:
    Article
    7
    8
    9

    Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced non-small-cell lung cancer: A case series of 20 patients.

    Published in:
    Molecular & Clinical Oncology, 2014, v. 2, n. 3, p. 454, doi. 10.3892/mco.2014.249
    By:
    • JUMPEI TAKESHITA;
    • KATSUHIRO MASAGO;
    • SHIRO FUJITA;
    • AKITO HATA;
    • REIKO KAJI;
    • TAKAHISA KAWAMURA;
    • KOJI TAMAI;
    • TAKESHI MATSUMOTO;
    • KAZUMA NAGATA;
    • KYOKO OTSUKA;
    • ATSUSHI NAKAGAWA;
    • KOJIRO OTSUKA;
    • KEISUKE TOMII;
    • TAKASHI SHINTANI;
    • KENJI TAKAYAMA;
    • MASAKI KOKUBO;
    • NOBUYUKI KATAKAMI
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17

    The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 74, n. 6, p. 1159, doi. 10.1007/s00280-014-2590-x
    By:
    • Shimizu, Ryoko;
    • Fujimoto, Daichi;
    • Kato, Ryoji;
    • Otoshi, Takehiro;
    • Kawamura, Takahisa;
    • Tamai, Koji;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Katakami, Nobuyuki;
    • Tomii, Keisuke
    Publication type:
    Article
    18

    Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice.

    Published in:
    Cancers, 2023, v. 15, n. 3, p. 970, doi. 10.3390/cancers15030970
    By:
    • Yamai, Takuo;
    • Ikezawa, Kenji;
    • Sugimoto, Naotoshi;
    • Urabe, Makiko;
    • Kai, Yugo;
    • Takada, Ryoji;
    • Nakabori, Tasuku;
    • Uehara, Hiroyuki;
    • Kawamura, Takahisa;
    • Kunimasa, Kei;
    • Yamamoto, Sachiko;
    • Wakamatsu, Toru;
    • Hayashi, Takuji;
    • Kukita, Yoji;
    • Fujisawa, Fumie;
    • Inoue, Tazuko;
    • Yamaguchi, Yuko;
    • Yamasaki, Tomoyuki;
    • Honma, Keiichiro;
    • Ohkawa, Kazuyoshi
    Publication type:
    Article
    19

    Features and prognostic impact of distant metastasis in patients with stage IV lung adenocarcinoma harboring EGFR mutations: importance of bone metastasis.

    Published in:
    Clinical & Experimental Metastasis, 2014, v. 31, n. 5, p. 543, doi. 10.1007/s10585-014-9648-3
    By:
    • Fujimoto, Daichi;
    • Ueda, Hiroyuki;
    • Shimizu, Ryoko;
    • Kato, Ryoji;
    • Otoshi, Takehiro;
    • Kawamura, Takahisa;
    • Tamai, Koji;
    • Shibata, Yumi;
    • Matsumoto, Takeshi;
    • Nagata, Kazuma;
    • Otsuka, Kyoko;
    • Nakagawa, Atsushi;
    • Otsuka, Kojiro;
    • Katakami, Nobuyuki;
    • Tomii, Keisuke
    Publication type:
    Article
    20
    21

    Real‐world assessment of comprehensive genome profiling impact on clinical outcomes: A single‐institution study in Japan.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 18, p. 1, doi. 10.1002/cam4.70249
    By:
    • Kunimasa, Kei;
    • Sugimoto, Naotoshi;
    • Yamasaki, Tomoyuki;
    • Kukita, Yoji;
    • Fujisawa, Fumie;
    • Inoue, Tazuko;
    • Yamaguchi, Yuko;
    • Kitasaka, Mitsuko;
    • Sakai, Daisuke;
    • Honma, Keiichiro;
    • Wakamatsu, Toru;
    • Yamamoto, Sachiko;
    • Hayashi, Takuji;
    • Mabuchi, Seiji;
    • Okuno, Jun;
    • Kawamura, Takahisa;
    • Kai, Yugo;
    • Urabe, Makiko;
    • Nishimura, Kazuo
    Publication type:
    Article
    22
    23
    24
    25

    Clinical application of comprehensive genomic profiling panel to thoracic malignancies: A single‐center retrospective study.

    Published in:
    Thoracic Cancer, 2022, v. 13, n. 21, p. 2970, doi. 10.1111/1759-7714.14643
    By:
    • Kunimasa, Kei;
    • Sugimoto, Naotoshi;
    • Kawamura, Takahisa;
    • Yamasaki, Tomoyuki;
    • Honma, Keiichiro;
    • Nagata, Shigenori;
    • Kukita, Yoji;
    • Fujisawa, Fumie;
    • Inoue, Tazuko;
    • Yamaguchi, Yuko;
    • Kitasaka, Mitsuko;
    • Wakamatsu, Toru;
    • Yamai, Takuo;
    • Yamamoto, Sachiko;
    • Hayashi, Takuji;
    • Inoue, Takako;
    • Tamiya, Motohiro;
    • Imamura, Fumio;
    • Nishimura, Kazuo;
    • Nishino, Kazumi
    Publication type:
    Article
    26
    27
    28

    Immunohistochemical analysis of B7-H3 expression in patients with lung cancer following various anti-cancer treatments.

    Published in:
    Investigational New Drugs, 2023, v. 41, n. 2, p. 356, doi. 10.1007/s10637-023-01353-8
    By:
    • Omori, Shota;
    • Muramatsu, Koji;
    • Kawata, Takuya;
    • Miyawaki, Eriko;
    • Miyawaki, Taichi;
    • Mamesaya, Nobuaki;
    • Kawamura, Takahisa;
    • Kobayashi, Haruki;
    • Nakashima, Kazuhisa;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Sugino, Takashi;
    • Takahashi, Toshiaki
    Publication type:
    Article
    29
    30

    Correction to: Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.

    Published in:
    2021
    By:
    • Inoue, Hiroto;
    • Ono, Akira;
    • Kawabata, Takanori;
    • Mamesaya, Nobuaki;
    • Kawamura, Takahisa;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Wakuda, Kazushige;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Yasui, Kazuaki;
    • Ogawa, Hirofumi;
    • Onoe, Tsuyoshi;
    • Endo, Masahiro;
    • Harada, Hideyuki;
    • Takahashi, Toshiaki
    Publication type:
    Correction Notice
    31

    Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma.

    Published in:
    Investigational New Drugs, 2021, v. 39, n. 2, p. 571, doi. 10.1007/s10637-020-01005-1
    By:
    • Kodama, Hiroaki;
    • Wakuda, Kazushige;
    • Yabe, Michitoshi;
    • Nishioka, Naoya;
    • Miyawaki, Eriko;
    • Miyawaki, Taichi;
    • Mamesaya, Nobuaki;
    • Kawamura, Takahisa;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Endo, Masahiro;
    • Takahashi, Toshiaki
    Publication type:
    Article
    32
    33

    Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer.

    Published in:
    Investigational New Drugs, 2020, v. 38, n. 5, p. 1612, doi. 10.1007/s10637-020-00917-2
    By:
    • Inoue, Hiroto;
    • Ono, Akira;
    • Kawabata, Takanori;
    • Mamesaya, Nobuaki;
    • Kawamura, Takahisa;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Wakuda, Kazushige;
    • Kenmotsu, Hirotsugu;
    • Naito, Tateaki;
    • Murakami, Haruyasu;
    • Yasui, Kazuaki;
    • Ogawa, Hirofumi;
    • Onoe, Tsuyoshi;
    • Endo, Masahiro;
    • Harada, Hideyuki;
    • Takahashi, Toshiaki
    Publication type:
    Article
    34
    35
    36
    37

    Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer.

    Published in:
    Supportive Care in Cancer, 2021, v. 29, n. 7, p. 3961, doi. 10.1007/s00520-020-05953-5
    By:
    • Okayama, Taro;
    • Naito, Tateaki;
    • Yonenaga, Yusuke;
    • Ohashi, Takuya;
    • Kitagawa, Midori;
    • Mitsuhashi, Noriko;
    • Ishi, Takeshi;
    • Fuseya, Hiroshi;
    • Aoyama, Takashi;
    • Notsu, Akifumi;
    • Mori, Keita;
    • Mamesaya, Nobuaki;
    • Kawamura, Takahisa;
    • Kobayashi, Haruki;
    • Omori, Shota;
    • Wakuda, Kazushige;
    • Ono, Akira;
    • Kenmotsu, Hirotsugu;
    • Murakami, Haruyasu;
    • Tanuma, Akira
    Publication type:
    Article
    38
    39